The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An
Activating Transcription Factor 3
/ metabolism
Animals
Carvedilol
/ pharmacology
Cell Shape
/ drug effects
Cell Survival
/ drug effects
Diabetic Neuropathies
/ metabolism
Ganglia, Spinal
/ drug effects
Glucose
/ metabolism
Male
Mice, Inbred C57BL
Neurons
/ drug effects
Neuroprotective Agents
/ pharmacology
Tissue Culture Techniques
Journal
Journal of diabetes research
ISSN: 2314-6753
Titre abrégé: J Diabetes Res
Pays: England
ID NLM: 101605237
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
05
2020
revised:
23
12
2020
accepted:
06
01
2021
entrez:
3
2
2021
pubmed:
4
2
2021
medline:
4
11
2021
Statut:
epublish
Résumé
Diabetic neuropathy serves as a major complication for diabetic patients across the world. The use of effective treatment is integral for reducing the health complications for diabetic patients. This study has evaluated the carvedilol potential neuroprotective effect on diabetic neuropathy. An
Identifiants
pubmed: 33532503
doi: 10.1155/2021/6927025
pmc: PMC7834839
doi:
Substances chimiques
Activating Transcription Factor 3
0
Atf3 protein, mouse
0
Neuroprotective Agents
0
Carvedilol
0K47UL67F2
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6927025Informations de copyright
Copyright © 2021 Rania M. Magadmi et al.
Déclaration de conflit d'intérêts
The author declares that there is no conflict of interest regarding the publication of this paper.
Références
Trends Immunol. 2004 Jan;25(1):4-7
pubmed: 14698276
J Diabetes Investig. 2011 Jan 24;2(1):33-42
pubmed: 24843458
Neuroscience. 2013 Mar 1;232:64-73
pubmed: 23262239
Indian J Psychol Med. 2020 Jul 14;42(4):394-396
pubmed: 33402802
Diabetes Ther. 2019 Jun;10(3):1099-1111
pubmed: 31028685
Cell. 2009 Oct 16;139(2):267-84
pubmed: 19837031
Curr Med Res Opin. 2019 Nov;35(11):1885-1891
pubmed: 31234649
Cardiovasc Diabetol. 2019 Nov 27;18(1):163
pubmed: 31775749
N Engl J Med. 2000 Mar 30;342(13):905-12
pubmed: 10738048
Hypertension. 2017 Jul;70(1):103-110
pubmed: 28559400
Neural Regen Res. 2018 Sep;13(9):1628-1636
pubmed: 30127125
Cell Stress Chaperones. 2018 Jul;23(4):695-702
pubmed: 29435723
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Eur J Clin Pharmacol. 1990;38 Suppl 2:S82-8
pubmed: 1974511
Brain Res Bull. 2012 Jan 4;87(1):85-93
pubmed: 22051611
Hypertension. 2001 Apr;37(4):1053-9
pubmed: 11304502
Expert Opin Drug Discov. 2009 Oct 1;4(10):1035-1045
pubmed: 20657751
Inflammopharmacology. 2017 Aug;25(4):393-402
pubmed: 28353124
Pharmacology. 1989;39(5):327-36
pubmed: 2575762
Clin Geriatr Med. 2008 Aug;24(3):489-501, vi-vii
pubmed: 18672184
Mol Cell Neurosci. 2000 Feb;15(2):170-82
pubmed: 10673325
Neurochem Res. 2014 Sep;39(9):1733-40
pubmed: 24952068
Hypertens Res. 2004 Apr;27(4):271-82
pubmed: 15127885
J Peripher Nerv Syst. 2004 Dec;9(4):242-54
pubmed: 15574137
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD007543
pubmed: 22696371
Toxicol Appl Pharmacol. 2013 Apr 15;268(2):241-8
pubmed: 23360886
Neurology. 2013 Sep 3;81(10):896-903
pubmed: 23911756
Diabetologia. 2019 Apr;62(4):676-686
pubmed: 30627753
Neurobiol Dis. 2006 Dec;24(3):525-30
pubmed: 17010629
Toxicol Appl Pharmacol. 2017 May 1;322:97-103
pubmed: 28286117
J Diabetes Complications. 2018 Feb;32(2):203-209
pubmed: 29242016
Nat Rev Neurosci. 2001 Feb;2(2):83-91
pubmed: 11252998
J Pain Res. 2011 Feb 14;4:55-65
pubmed: 21559351
Exp Neurol. 2007 Dec;208(2):216-27
pubmed: 17927981
Diabetes Metab Syndr Obes. 2018 Jun 22;11:313-319
pubmed: 29950877
Eur J Clin Invest. 2017 Jan;47(1):19-29
pubmed: 27805735